Cargando…
Hepatitis following famotidine: a case report
H2 receptor antagonists can rarely cause idiosyncratic drug reactions leading to acute hepatitis. Famotidine, however, is considered a relatively safe drug with regards to hepatotoxicity. We report a case of a 47 year old male with a history of hepatitis C who developed acute hepatitis on the third...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640350/ https://www.ncbi.nlm.nih.gov/pubmed/19173722 http://dx.doi.org/10.1186/1757-1626-2-89 |
_version_ | 1782164560191422464 |
---|---|
author | Gupta, Nishant Patel, Chirag Panda, Mukta |
author_facet | Gupta, Nishant Patel, Chirag Panda, Mukta |
author_sort | Gupta, Nishant |
collection | PubMed |
description | H2 receptor antagonists can rarely cause idiosyncratic drug reactions leading to acute hepatitis. Famotidine, however, is considered a relatively safe drug with regards to hepatotoxicity. We report a case of a 47 year old male with a history of hepatitis C who developed acute hepatitis on the third day of hospitalization with a dramatic rise in his liver enzymes from normal values at the time of admission. The acute rise in liver enzymes made us consider an adverse drug reaction and famotidine was discontinued. Subsequently his liver enzymes came back to normal in seven days. Thus, physicians should consider famotidine induced hepatitis as a possible etiology of acute liver dysfunction. |
format | Text |
id | pubmed-2640350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26403502009-02-12 Hepatitis following famotidine: a case report Gupta, Nishant Patel, Chirag Panda, Mukta Cases J Case Report H2 receptor antagonists can rarely cause idiosyncratic drug reactions leading to acute hepatitis. Famotidine, however, is considered a relatively safe drug with regards to hepatotoxicity. We report a case of a 47 year old male with a history of hepatitis C who developed acute hepatitis on the third day of hospitalization with a dramatic rise in his liver enzymes from normal values at the time of admission. The acute rise in liver enzymes made us consider an adverse drug reaction and famotidine was discontinued. Subsequently his liver enzymes came back to normal in seven days. Thus, physicians should consider famotidine induced hepatitis as a possible etiology of acute liver dysfunction. BioMed Central 2009-01-27 /pmc/articles/PMC2640350/ /pubmed/19173722 http://dx.doi.org/10.1186/1757-1626-2-89 Text en Copyright ©2009 Gupta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Gupta, Nishant Patel, Chirag Panda, Mukta Hepatitis following famotidine: a case report |
title | Hepatitis following famotidine: a case report |
title_full | Hepatitis following famotidine: a case report |
title_fullStr | Hepatitis following famotidine: a case report |
title_full_unstemmed | Hepatitis following famotidine: a case report |
title_short | Hepatitis following famotidine: a case report |
title_sort | hepatitis following famotidine: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640350/ https://www.ncbi.nlm.nih.gov/pubmed/19173722 http://dx.doi.org/10.1186/1757-1626-2-89 |
work_keys_str_mv | AT guptanishant hepatitisfollowingfamotidineacasereport AT patelchirag hepatitisfollowingfamotidineacasereport AT pandamukta hepatitisfollowingfamotidineacasereport |